Continence Care Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Continence Care Market Analysis

The Continence Care Market size is estimated at USD 7.32 billion in 2024, and is expected to reach USD 9.85 billion by 2029, growing at a CAGR of 6.11% during the forecast period (2024-2029).

The continence care market is anticipated to grow due to the high burden of incontinence and chronic diseases, increasing demand for minimally invasive continence care products and technological advancements, and the rising geriatric population.

Several sources have highlighted that the prevalence of incontinence and chronic diseases, such as diabetes, urinary tract infections, and kidney stones, are on the rise, which is anticipated to create a large patient base for incontinence that will boost the demand for continence care products. For instance, the data published by the BMC Urology Journal in December 2023 mentioned that in Turkey, 8.8% of the population experienced urinary incontinence, with a significant gender gap. Women were disproportionately affected, with a prevalence of 11.2%, compared to 5.5% in men. Additionally, another article published in the DovePress in August 2023 mentioned that female urinary incontinence (UI) affected 24.8% of women studied in Southeastern China, with stress UI being the most prevalent subtype at 12.7%. Mixed UI was the second most common subtype at 8.0%, followed by urgency UI at 4.1%. Thus, due to the high prevalence of urinary incontinence, the demand for continence care products is expected to rise and drive market growth.

Moreover, underlying chronic medical diseases such as diabetes also cause urinary incontinence, and their increasingly high prevalence is expected to expand the number of patients, which will elevate the demand for continence care products. For instance, according to data updated by the International Diabetes Federation in 2024, the number of diabetes cases is estimated to increase, reaching 643 million by 2030 and 783 million by 2045. Additionally, an article published in the JU Open Plus Journal in January 2024 mentioned that kidney stones are estimated to affect 9.9% of the US population, which accounts for approximately 23.7 million people. Thus, with such a vast patient base of diabetic and kidney stone patients, the demand for continence care products is expected to increase to manage urinary incontinence cases, boosting market growth.

In addition, several market players have received regulatory approval and launched advanced and minimally invasive products, increasing the penetration of continence care products. This is expected to boost market growth in the coming years. For instance, in April 2023, Avation Medical Inc. received the US Food and Drug Administration’s (FDA) 510(k) clearance for its Vivally System. The device is a non-invasive bladder control therapy device and mobile application that is intended to treat urinary urgency and urge urinary incontinence (UUI) caused by overactive bladder syndrome. Additionally, in January 2023, Zida launched its neuromodulation device garment, the Zida Control Sock, which is intended to manage overactive bladder and incontinence symptoms. The device stimulates the transcutaneous tibial nerve to treat overactive bladder and incontinence.

Further, in June 2022, Valencia Technologies Corporation completed the world's first commercial implantation of eCoin in the United States. The device is a tibial neurostimulator indicated for the treatment of urge urinary incontinence. Also, in March 2022, Valencia Technologies Corporation received premarket approval (PMA) from the US Food and Drug Administration for its eCoin, which is a leadless tibial neurostimulator. Thus, with the launch of such advanced products for incontinence management, the market penetration and adoption of continence products will increase. These factors are anticipated to boost market growth in the coming years.

Therefore, owing to the factors above, such as the high prevalence of urinary incontinence and chronic diseases, along with new product launches, the market is anticipated to grow over the forecast period. However, the lack of awareness about incontinence and skilled continence care specialists and the high cost of the products are likely to impede market growth.

Continence Care Market Trends

The Electrical Stimulation Devices Segment is Expected to Witness Significant Growth Over the Forecast Period

Continence Care Industry Segmentation

As per the scope of the report, continence care products include medical devices, accessories, and products used to manage incontinence, which is caused by the loss of control over the pelvic muscles due to underlying chronic disease or spinal bifida or injury. The continence care market is segmented by product, indication, end-user, and geography. By product, the market is segmented into urinary catheters, non-implanting electric stimulation devices, protective garments, urine bags, bowel management products, and other products. By urinary catheters, the market is further sub-segmented into indwelling (foley)catheters, intermittent catheters, and external catheters. By non-implanting electric stimulation devices, the market is further sub-segmented into urethral slings, electrical stimulation devices, and artificial urinary sphincters. By protective garments, the market is further sub-segmented into disposable adult diapers, disposable underpads, and disposable pull-up pants. By urine bag, the market is further sub-segmented into leg urine bags and bedside urine bags. By bowel management products, the market is further sub-segmented into anal plugs, bowel irrigation systems, and enemas. By indication, the market is segmented into fecal incontinence care, urinary incontinence care, and other indications. By end user, the market is segmented into acute care facilities, long-term care facilities, home care, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size is provided in terms of value (USD).